| Age(years) |
Gender |
Time since initial therapy (years) |
Current therapy |
Prior use of alternative |
| 3 |
F |
0.5 |
Transfusion/Oral chelation |
No |
| 5 |
M |
2.3 |
Transfusion/Oral chelation |
No |
| 10 |
M |
2.8 |
Transfusion/Oral chelation |
Hydroxyurea |
| 12 |
M |
1.2 |
Transfusion/Oral chelation |
Hydroxyurea |
| 12 |
F |
5 |
Transfusion/Oral chelation |
No |
| 13 |
M |
7.2 |
Transfusion/Oral chelation |
Hydroxyurea/phlebotomy |
| 14 |
M |
13.4 |
Pheresis |
Hydroxyurea/phlebotomy |
| 16 |
M |
10.2 |
Pheresis |
Hydroxyurea/phlebotomy |
| 16 |
F |
2.4 |
Pheresis/Oral chelation |
Hydroxyurea/phlebotomy |
| 8 |
M |
3.7 |
Hydroxyurea |
Transfusion/chelation/phlebotomy |
| 12 |
M |
6.6 |
Hydroxyurea |
Transfusion/chelation/phlebotomy |
| 13 |
M |
12.7 |
Hydroxyurea |
Transfusion/chelation/phlebotomy |
| 14 |
F |
7.9 |
Hydroxyurea |
No |
| 17 |
M |
8.4 |
Hydroxyurea |
Transfusion/chelation/phlebotomy |
